To determine whether genetic mechanisms control large variations in cytosolic epoxide hydrolase (cEH) activity of unstimulated lymphocytes from normal human subjects, cEH activity was measured in (a) 6 sets of monozygotic (MZ) twins and 6 sets of dizygotic (DZ) twins; (b) 100 unrelated male subjects; and (c) 6 families. The twin study revealed predominantly genetic control (H2(1) = 0.95). Variability was markedly less within MZ (intrapair variance = 0.25) than DZ twins (intrapair variance = 6.33). In 100 unrelated male subjects the extent of interindividual variation was 11-fold. Unimodal distribution of values among 99 subjects encompassed a sixfold range. One outlier with very high activity clearly stood apart. Using the whole distribution curve we phenotyped members of six families. In the outlier's family, analysis of three generations suggested autosomal dominant transmission of high cEH activity. Analysis of the other 5 families and of 12 sets of twins, all from the large unimodal distribution, was consistent with either monogenic or polygenic control of variations within this mode. Several temporal host factors, including fever, the menstrual cycle, a 24-h fast, and diurnal variations, were investigated. Fever and fasting elevated cEH activity. Diurnal variations produced no observable alteration. During the menstrual cycle irregular fluctuations occurred.
K K Norris, T M DeAngelo, E S Vesell
Title and authors | Publication | Year |
---|---|---|
Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases
T Duflot, C Roche, F Lamoureux, D Guerrot, J Bellien |
Expert Opinion on Drug Discovery | 2014 |
The genetics of vascular incidents associated with second-generation antipsychotic administration
E Cocchi, A Drago, D Ronchi, A Serretti |
Expert Review of Clinical Pharmacology | 2014 |
Pharmacogenetics and Individualized Therapy: Maitland-van der Zee/Pharmacogenetics
B Sobrino, A Carracedo |
Pharmacogenetics and Individualized Therapy: Maitland-van der Zee/Pharmacogenetics | 2012 |
Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases
BN Zordoky, AO El-Kadi |
Pharmacology & Therapeutics | 2010 |
Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent
JJ Iliff, NJ Alkayed |
Future Neurology | 2009 |
In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood
B Paulsson, A Rannug, AP Henderson, BT Golding, M Törnqvist, M Warholm |
Mutation Research/Genetic Toxicology and Environmental Mutagenesis | 2005 |
Vascular localization of soluble epoxide hydrolase in the human kidney
Z Yu, BB Davis, C Morisseau, BD Hammock, JL Olson, DL Kroetz, RH Weiss |
American journal of physiology. Renal physiology | 2004 |
Polymorphisms in Human Soluble Epoxide Hydrolase
BD Przybyla-Zawislak, PK Srivastava, J Vázquez-Matías, HW Mohrenweiser, JE Maxwell, BD Hammock, JA Bradbury, AE Enayetallah, DC Zeldin, DF Grant |
Molecular pharmacology | 2003 |
Cancer and Pregnancy
ER Barnea, E Jauniaux, PE Schwartz |
2001 | |
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
Z Yu, F Xu, LM Huse, C Morisseau, AJ Draper, JW Newman, C Parker, L Graham, MM Engler, BD Hammock, DC Zeldin, DL Kroetz |
Circulation research | 2000 |
Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms
M Sandberg, C Hassett, ET Adman, J Meijer, CJ Omiecinski |
The Journal of biological chemistry | 2000 |
Epoxide hydrolase activity in human blood mononuclear leukocytes: individual differences in native and mitogen-stimulated cells
S Bernardini, H Norppa, E Elovaara |
Mutation Research/Genetic Toxicology and Environmental Mutagenesis | 1999 |
Handbook of Drug Metabolism
S Vee, W Day |
Handbook of Drug Metabolism: Mechanisms and Implications | 1999 |
Molecular basis of polymorphic drug metabolism
AK Daly |
Journal of Molecular Medicine | 1995 |
Metabolic polymorphisms
AK Daly, S Cholerton, W Gregory, JR Idle |
Pharmacology & Therapeutics | 1993 |
Some substrates and inhibitors of cytosolic epoxide hydrolase induce sister-chromatid exchanges in mammalian cells, but do not induce gene mutations in Salmonella typhimurium and V79 cells
A Krämer, J Pudil, H Frank, F Oesch, H Glatt |
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 1993 |
Biologic Rhythms in Clinical and Laboratory Medicine
Y Touitou, E Haus |
1992 | |
Genetic and environmental factors causing variation in drug response
ES Vesell |
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 1991 |